COMMANDER II
by Cardiocom
510(k) K043096
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK043096 | Date24 Nov 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXN
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1130
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The COMMANDER II is a vital sign telemonitoring system designed to enable health care professionals to remotely monitor patients' vital signs. It is substantially equivalent to the Home Care Monitoring System, AvidCare Corp., K010029, and was cleared by the FDA under 510(k) K043096.
The device is supplied as a vital sign telemonitoring system with a screen and is intended for remote patient monitoring. It is a single-use device, and its storage and sterilization requirements are not specified in the provided data.
Other devices from Cardiocom, LLC
Questions
AI-generated answers, 23 Sep 2026
What is the COMMANDER II used for?
The COMMANDER II is a vital sign telemonitoring system with a screen. It is intended for remote patient monitoring, enabling health care professionals to monitor patients' vital signs from a distance.
Is the COMMANDER II a single-use device?
Yes, the COMMANDER II is a single-use device. The provided data does not specify any requirements for its reuse.
How is the COMMANDER II supplied?
The device is supplied as a vital sign telemonitoring system with a screen. It is intended for remote patient monitoring.
What is the regulatory status of the COMMANDER II?
The COMMANDER II was substantially equivalent to the Home Care Monitoring System, AvidCare Corp., K010029, and was cleared by the FDA under 510(k) K043096.